Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Technetium Tc-99m Mertiatide Kit Patent Expiration

Technetium Tc-99M Mertiatide Kit is used for treating erectile dysfunction. It was first introduced by Curium Us Llc in its drug Technescan Mag3 on Jun 15, 1990. Another drug containing Technetium Tc-99M Mertiatide Kit is Technetium Tc 99M Mertiatide Kit. 4 different companies have introduced drugs containing Technetium Tc-99M Mertiatide Kit.


Technetium Tc-99m Mertiatide Kit Patents

Given below is the list of patents protecting Technetium Tc-99m Mertiatide Kit, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Technescan Mag3 US5573748 Radiolabeled technetium chelates for use in renal function determinations Nov 12, 2013

(Expired)

 Curium



Technetium Tc-99m Mertiatide Kit's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Technetium Tc-99m Mertiatide Kit Generic API Manufacturers

Several generic applications have been filed for Technetium Tc-99M Mertiatide Kit. The first generic version for Technetium Tc-99M Mertiatide Kit was by Sun Pharmaceutical Industries Inc and was approved on Jul 12, 2019. And the latest generic version is by Medi-Radiopharma Ltd and was approved on Feb 6, 2020.

Given below is the list of companies who have filed for Technetium Tc-99m Mertiatide Kit generic, along with the locations of their manufacturing plants worldwide.